Specialists from the "Sirius" University are developing a new method for diagnosing age-related and oncological diseases. This was reported by the press service of the university.
Scientists believe that the risk of developing age-related diseases is associated with a lack of vitamin B12. They are developing a non-invasive molecular tool for the quantitative measurement of vitamin B12 in human cells. For this, it is planned to use Kamchatka bacteria.
This is a representative of the archaea kingdom Thermogladius calderae, bacteria Fervidicoccus fontis and Fervidobacterium riparium.
Fluorescent proteins (a family of light-absorbing proteins) are integrated into the cell membrane of bacteria. With their help, the developers determine the concentration of vitamin B12 in the human body.
Currently, Sirius specialists are exploring the ability of proteins to bind to vitamin B12. The first prototype of the molecular tool will appear in the near future.
Earlier, www1.ru reported that scientists from Saratov came up with how to treat brain cancer in a dream.
Read materials on the topic:
An effective drug to fight cancer has been developed in Nizhny Novgorod
Rosatom has developed a new technology for producing a drug for cancer treatment
A mobile radiation therapy complex is being developed in Russia